-
Revitalising sentiment for the sector following ASP hike due to the ongoing Iran war, Andes hantavirus outbreak and improving earnings outlook prompted us to upgrade our valuations peg from -0.5 standard deviation to mean.
-
Nevertheless, top-line pressure from the weakening MYR/US$rate, potential ASP and margins normalisation when the Iran war de-escalates, and China’s capacity influx remain as mid-long-term challenges.
- - Read this at SGinvestors.io -
Recent hantavirus outbreak unlikely to evolve into COVID 2.0.
-
The recent Andes hantavirus infections on a cruise ship are casting concerns on another global-wide outbreak like COVID-19. This Andes hantavirus outbreak has caused three death tolls and eight confirmed cases thus far. Nevertheless, the World Health Organisation says that the risk of a major outbreak from hantavirus is very low, with various pre-emptive efforts such as quarantine arrangements being carried out. As such, we do not foresee the glove industry benefiting meaningfully for now, unless the situation deteriorates.
Operational recovery underway, building up favourable trading momentum...
- - Read this at SGinvestors.io -
…but restoration to pre-pandemic’s earnings dynamic remains difficult.
- Read more at SGinvestors.io.
Above is an excerpt from a report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full PDF report @ https://www.utrade.com.sg/.
Jack Goh UOB Kay Hian Research | https://research.uobkayhian.com/ 2026-05-13
Read also UOB's most recent report:
2026-06-19 Top Glove 3QFY26 - Windfall Quarter; Gradual Normalisation Ahead.
Price targets by 2 other brokers at Top Glove Target Prices.
Listing of research reports at Top Glove Analyst Reports.
Relevant links:
Top Glove Share Price History,
Top Glove Announcements,
Top Glove Dividend Payout Dates & Corporate Actions,
Top Glove News
